33
Participants
Start Date
July 31, 2008
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2012
Virtual Bone Biopsy
MRI technology allowing generation of 3D images with considerably smaller voxel size than previous technology through the use of novel pulse sequences and advanced interpolation techniques.
Teriparatide
Participants are clinically indicated for treatment.
Zoledronic Acid
Participants are clinically indicated for treatment.
University of Pennsylvania, Philadelphia
Collaborators (1)
Eli Lilly and Company
INDUSTRY
Novartis Pharmaceuticals
INDUSTRY
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
University of Pennsylvania
OTHER